J Neurol Surg A Cent Eur Neurosurg 2016; 77(02): 093-101
DOI: 10.1055/s-0035-1559809
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Endoscopic Biopsy for Intra- and Paraventricular Tumors: Rates of Complications, Mortality, and Tumor Cell Dissemination

Anna Katharina Krähenbühl
1   Department of Neurosurgery, Bern University Hospital, Inselspital, Bern, Switzerland
,
Jörg Baldauf
2   Department of Neurosurgery, Ernst Moritz Arndt University, Greifswald, Germany
,
Susanne Guhl
2   Department of Neurosurgery, Ernst Moritz Arndt University, Greifswald, Germany
,
Michael R. Gaab
3   Department of Neurosurgery, Nordstadtkrankenhaus, Hannover, Germany
,
H.W.S W. S. Schroeder
2   Department of Neurosurgery, Ernst Moritz Arndt University, Greifswald, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

05. August 2014

24. April 2015

Publikationsdatum:
24. August 2015 (online)

Preview

Abstract

Background and Study Aim Intra- and paraventricular tumors are frequently associated with cerebrospinal fluid (CSF) pathway obstruction. Thus the aim of an endoscopic approach is to restore patency of the CSF pathways and to obtain a tumor biopsy. Because endoscopic tumor biopsy may increase tumor cell dissemination, this study sought to evaluate this risk.

Patients, Materials, and Methods Forty-four patients who underwent endoscopic biopsies for ventricular or paraventricular tumors between 1993 and 2011 were included in the study. Charts and images were reviewed retrospectively to evaluate rates of adverse events, mortality, and tumor cell dissemination. Adverse events, mortality, and tumor cell dissemination were evaluated.

Results Postoperative clinical condition improved in 63.0% of patients, remained stable in 30.4%, and worsened in 6.6%. One patient (2.2%) had a postoperative thalamic stroke leading to hemiparesis and hemineglect. No procedure-related deaths occurred. Postoperative tumor cell dissemination was observed in 14.3% of patients available for follow-up.

Conclusions For patients presenting with occlusive hydrocephalus due to tumors in or adjacent to the ventricular system, endoscopic CSF diversion is the procedure of first choice. Tumor biopsy in the current study did not affect safety or efficacy.